Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
13.60
0.13 (0.97%)
At close: May 14, 2025, 3:59 PM
13.59
-0.07%
After-hours: May 14, 2025, 05:40 PM EDT
Keros Therapeutics Revenue
Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending March 31, 2025, Keros Therapeutics generated $211.25M in revenue.
Revenue (ttm)
$3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
$21.01K
Employees
169
Market Cap
552.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|